Vertex Q2 Revenue Beats, Adjusted EPS Narrowly Misses, FY26 Revenue Guidance Raised

SentiSense · Published Aug 3, 2026, 4:36 PM ET · Updated Aug 4, 2026, 4:23 PM ET

Vertex Pharmaceuticals (VRTX) reported Q2 2026 revenue of $3.33 billion, up 12.4% and ahead of the $3.22 billion consensus, while adjusted EPS of $4.7...